| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.00055 | 1 |